Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome : a retrospective study from The Korean Society of Hematology AML/MDS Working Party

Author:

Kim Da Jung1,Lee Ho Sup1,Moon Joon-Ho2,Sohn Sang Kyun2,Kim Hyeoung Joon3,Cheong June-Won4,Jo Deog-Yeon5,Kim Hawk6,Lee Hyewon7,Bang Soo-Mee8,Lee Won Sik9,Park Yong10,Lee Mark Hong11,Lee Jae Hoon12,Bae Sung Hwa13,Kim Min Kyoung14,

Affiliation:

1. Department of Internal Medicine, Kosin University College of Medicine, Kosin University Gospel Hospital, Busan, South Korea

2. Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, South Korea

3. Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Jeollanamdo, South Korea

4. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea

5. Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University, Daejeon, South Korea

6. Division of Hematology and Cellular Therapy, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, South Korea

7. Department of Hematology-Oncology, Center for Hematologic Malignancy, National Cancer Center, Goyang, South Korea

8. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul, South Korea

9. Department of Internal Medicine, Busan Paik Hospital, Busan, South Korea

10. Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea

11. Division of Hematology-Oncology, Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, South Korea

12. Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, South Korea

13. Department of Internal Medicine, Daegu Catholic University Medical Center, Daegu, South Korea

14. Department of Hematology-Oncology, Yeungnam University Medical Center, Yeungnam University School of Medicine, Daegu, South Korea

Publisher

Impact Journals, LLC

Subject

Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3